News

Red Tree News

• October 6, 2022

BioCentury: Lukatch, Cochran Backing West Coast Spinouts with Red Tree’s $272M First Fund

Red Tree News

• October 6, 2022

Timmerman Report: Red Tree Debuts With $272M, Zeroing In On West Coast Startups

Red Tree News

• October 6, 2022

Red Tree Venture Capital Announces Closing of $272 Million Inaugural Fund

Portfolio News

• September 21, 2022

Ceribell Closes $50 Million Equity Financing Round Led by Ally Bridge Group

Portfolio News

• September 8, 2022

Ceribell Receives FDA Breakthrough Device Designation for Delirium Indication

Portfolio News

• September 6, 2022

Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System for Non-Invasive, Individualized and Precise Treatment of Severe Depression

Portfolio News

• July 7, 2022

Magnus Medical Featured on The Today Show – Magnet Therapy Brings Hope to People with Depression

Portfolio News

• June 22, 2022

Alladapt Announces Completion of Oversubscribed $119 Million Institutional Financing

Portfolio News

• March 28, 2022

Pipeline Therapeutics Receives IND Clearance from FDA to Initiate Phase 1b/2a Study of PIPE-307 in Patients with Relapsing-Remitting Multiple Sclerosis

Portfolio News

• March 17, 2022

Alladapt Announces Initiation of Encore Open-Label Extension Study for its Harmony Phase 1/2 Study of ADP101 for Treatment of Food Allergy

Portfolio News

• March 10, 2022

Pipeline Therapeutics Reports Positive Phase 1 Clinical Results for PIPE-307, a Neuroregenerative Therapeutic for the Treatment of Multiple Sclerosis

Portfolio News

• March 2, 2022

Rondo Therapeutics Closes $67 Million Series A Financing to Advance NextGeneration Immuno-Oncology Platform for Solid Tumors

Portfolio News

• September 28, 2021

Acrigen Biosciences Raises Seed Financing to Advance Precision Gene Editing Technology and Therapeutic Pipeline